AML3D (ASX: AL3) Jumps 8.93%: Can Record FY26 Revenue Reset the Growth Story?

Aditi Sarkar

01 September 2026 02:22 PM AEST

AML3D (ASX: AL3) Jumps 8.93%: Can Record FY26 Revenue Reset the Growth Story?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

AML3D lifted FY26 Revenue including Lease income 70% year on year to AUD 12.5mn.
The company recorded AUD 608,000 of EBITDA in the second half of FY26.
Confirmed order book peaked at AUD 29mn during FY26, with AUD 16.8mn rolling into FY27.
AL3 shares rose 8.93% to AUD 0.153 at the time of writing on 1 September 2026.

AML3D (ASX: AL3) shares rose 8.93% to AUD 0.153 at the time of writing on 1 September 2026. Behind the market move sits a company entering FY27 with a very different operating profile: record FY26 revenue, second-half EBITDA, a sizeable rollover of contracted work and a growing sales pipeline. The latest company update also points to deeper penetration of US defence and industrial Manufacturing markets.

Stock Price Snapshot

AML3D (ASX: AL3) was trading at AUD 0.153, up 8.93%, at the time of writing on 1 September 2026. Turnover stood at AUD 479,603, Market Capitalisation was AUD 86.54mn, and the stock’s one-year performance was -41.35%.

Record Revenue Changes the FY26 Starting Point

AML3D reported FY26 revenue including lease income of AUD 12.5mn, up 70% year on year. The company also recorded EBITDA of AUD 608,000 in the second half, marking a shift in the financial profile across the year. The results provide the clearest starting point for assessing the company’s next phase.

Orders Stretch Into FY27

The confirmed order book reached an intra-year peak of AUD 29mn during FY26. Importantly, AUD 16.8mn of contract work is rolling into FY27, compared with AUD 9mn a year earlier. That rollover gives the new financial year an existing base of contracted activity.

US Defence Becomes a Larger Part of the Picture

AML3D has continued to build its presence in the US defence market. In June, the company announced commissioning of two custom ARCEMY X systems at Newport News Shipbuilding, completing an initial order worth about AUD 4.5mn. A second order for four additional systems, worth about AUD 9.9mn, was also tracking for delivery in early 2027.

The Pipeline Is Now the Next Test

AML3D ended FY26 with an estimated global sales pipeline of AUD 78mn. The company has also pointed to Diversification into UK defence and high-value industrial manufacturing in the US. The next stage will be converting that pipeline and contracted rollover into FY27 deliveries and revenue.

FAQs

Q: What was AML3D’s FY26 revenue?

A: AML3D reported FY26 revenue including lease income of AUD 12.5mn.

Q: What was the FY26 second-half EBITDA?

A: The company reported EBITDA of AUD 608,000 for the second half of FY26.

Q: How much work is rolling into FY27?

A: AUD 16.8mn of contract work is rolling into FY27.

Q: What was the AL3 share price?

A: AL3 shares rose 8.93% to AUD 0.153 at the time of writing on 1 September 2026.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.